BioXcel Therapeutics, Inc. (BTAI)

BioXcel Therapeutics Revenue

BioXcel Therapeutics had revenue of $120.00K in the quarter ending June 30, 2025, a decrease of -89.13%. This brings the company's revenue in the last twelve months to $868.00K, down -63.88% year-over-year. In the year 2024, BioXcel Therapeutics had annual revenue of $2.27M with 64.20% growth.

• Revenue (ttm): $868.00K
• Revenue Growth: -63.88%
• P/S Ratio: 29.66
• Revenue / Employee: $23,459
• Employees: 37
• Market Cap: 33.91M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.27M	886.00K	64.20%
Dec 31, 2023	1.38M	1.01M	268.00%
Dec 31, 2022	375.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.